Welcome back to Part Two of our series, the Economics of Weight Loss Drugs. (If you haven’t heard Part One, listen here!)
Today, we’re picking back up where we left off in our conversation with Lili Zarghami, a writer who got on (then off) a weight loss drug. Then we’ll talk with Dr. Mara Gordon, a weight-neutral physician who deals with GLP-1s. Finally, I’ll share my final thoughts and analysis on where the world of GLP-1 agonists is all headed and what it says about health, wealth, stigma, and class.
Transcripts, show notes, production credits, and more can be found at: https://moneywithkatie.com/diet-culture.
Money with Katie’s mission is to be the intersection where the economic, cultural, and political meet the tactical, practical, personal finance education everyone needs.
Learn more about your ad choices. Visit megaphone.fm/adchoices
“You Just Have to Keep Buying”: How Diet Culture Profits from Fatphobia | The Money with Katie Show podcast - Listen or read transcript on Metacast
